Postmenopausal Osteoporosis
Postmenopausal osteoporosis, also called osteoporosis type I, usually develops in women after menopause. It is characterised by a sharp drop in estrogen levels. These changes lead to bone loss (decrease in bone mineral density), mostly in the trabecular (spongy) bone within the hard bone cortex. This increases the risk of bone fractures and can lead to disability or even death.
Reference Standard as Aliquots
Biosimilars as Aliquots
Access Batch Specific Analytical Information
Evidentic’s Analytical Data Service includes a comprehensive array of methods to support the drug development process, including structure, aggregation, degree of isomerization, and N-glycans identification of the active pharmaceutical ingredient (API).
Product Information
Here you will find the product information for the reference product.
Support
Do you have a question about the product? Reach out to our team using the form below – we’d be happy to help you!
Ready to simplify your sourcing?
Here’s how to get started:
Select Your Licensed Molecules
Browse our shop and choose the licensed molecule(s) you need. Don’t worry if you can’t find the molecule you’re looking for – we can source it for you!
Get a Quote
Receive a confidential, non-binding quote for the molecule(s) you choose.
Get Qualified & We Deliver
Complete our quick qualification process, place your order, and we’ll ship your molecule(s) within days.
Do you have a question you'd like to ask us?
Here’s how to get started:
